Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma von De Divitiis, C, von Arx, C, Grimaldi, A M, Cicala, D, Tatangelo, F, Arcella, A, Romano, G M, Simeone, E, Iaffaioli, R V, Ascierto, P A, Tafuto, S

Volltext

Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes von Calabrese, A., von Arx, C., Tafuti, A.A., Pensabene, M., De Laurentiis, M.

Volltext

Cancer genetic counselling for hereditary breast cancer in the era of precision oncology von Pensabene, M., Calabrese, A., von Arx, C., Caputo, R., De Laurentiis, M.

Volltext

Coulomb distortion of relativistic electrons in the nuclear electrostatic field von Aste, A., von Arx, C., Trautmann, D.

Volltext

QCD corrections to longitudinal spin asymmetries in W±-boson production at RHIC von von Arx, C., Gehrmann, T.

Volltext

A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase I... von von Arx, C., Della Vittoria Scarpati, G., Cannella, L., Clemente, O., Marretta, A.L., Bracigliano, A., Picozzi, F., Iervolino, D., Granata, V., Modica, R., Bianco, A., Mocerino, C., Di Mauro, A., Pizzolorusso, A., Di Sarno, A., Ottaiano, A., Tafuto, S.

Volltext

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment von Capozzi, Monica, De Divitiis, Chiara, Ottaiano, Alessandro, von Arx, Claudia, Scala, Stefania, Tatangelo, Fabiana, Delrio, Paolo, Tafuto, Salvatore

Volltext

1200P A phase II single-arm interventional trial evaluating the activity and safety of CABOzantinib (CBZ) plus TEMozolomide (TMZ) in lung and gastroenteropancreatic neuroendocrine... von Clemente, O., Starita, N., Bracigliano, A., Cives, M., Tatangelo, F., Barretta, M.L., Badalamenti, G., Lastoria, S., Picozzi, F., Di Mauro, A., von Arx, C., Cannella, L., Tafuto, S.

Volltext

449P Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) plus endocrine therapy (ET) treatment in metastatic lobular breast cancer (mLBC): A retrospective cohort study von von Arx, C., Calabrese, A., Martinelli, C., Di Lauro, V., Grimaldi, V., Pensabene, M., Caputo, R., Cerillo, I., Cianniello, D., Buono, G., Verrazzo, A., Pacilio, C., Di Rella, F., Nuzzo, F., De Laurentiis, M.

Volltext

1202P Final analysis of TENEC trial: A phase II trial of temozolomide (TMZ) as second-line treatment for advanced neuroendocrine carcinomas (NEC) in patients (pts) with a poor perf... von von Arx, C., Cannella, L., Marretta, A.L., Bracigliano, A., Tatangelo, F., Clemente, O., Iervolino, D., Granata, V., Mocerino, C., Modica, R., Pizzolorusso, A., Bianco, A., Picozzi, F., Di Sarno, A., Tafuto, S.

Volltext

105P CDK4/6 inhibitors in hormone receptor-positive, HER2-negative, locally advanced breast cancer (LABC): Biological and clinical activity, and post-surgical approaches von Parola, S., Di Lauro, V., De Placido, P., Forestieri, V., Buono, G., von Arx, C., Pietroluongo, E., Pagliuca, M., Cianniello, D., Lauria, R., Caputo, R., Arpino, G., de Placido, S., Giuliano, M., De Laurentiis, M., De Angelis, C.

Volltext

QCD corrections to longitudinal spin asymmetries in W±-boson production at RHIC von von Arx, C, Gehrmann, T

Volltext

Early identification of residual disease after neuroendocrine tumor resection using a liquid biopsy multigenomic mRNA signature (NETest) von Modlin, IM, Kidd, M, Oberg, K, Falconi, M, Filosso, PL, Frilling, A, Malczewska, A, Salem, R, Toumpanakis, C, Laskaratos, F-M, Partelli, S, Roffinella, M, Von Arx, C, Kudla, BK, Bodei, L, Drozdov, IA, Kitz, A

Volltext

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions von Birtley, JR, Alomary, M, Zanini, E, Antony, J, Maben, Z, Weaver, G, Von Arx, C, Mura, M, Marinho, AT, Lu, H, Morecroft, E, Karali, E, Chayen, N, Tate, E, Jurewicz, M, Stern, L, Recchi, C, Gabra, H

Volltext

158TiP Neoadjuvant abemaciclib and giredestrant trial in patients with ER-positive, HER2-negative early breast cancer (GIM31-Neo-AGILE trial) von von Arx, C., Calabrese, A., Caputo, R., Di Lauro, V., Pensabene, M., Buono, G., Fabi, A., Cognetti, F., Guarneri, V., Puglisi, F., Vigneri, P., Del Mastro, L., Arpino, G., De Laurentiis, M.

Volltext

Regularization in quantum field theory from the causal point of view von Aste, A., von Arx, C., Scharf, G.

Volltext

Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors von Ottaviano, M., Damiano, V., Nappi, L., Rescigno, P., Montella, L., Marino, M., Del Vecchio, S., Tucci, I., von Arx, C., Matano, E., Palmieri, G.

Volltext

1200V IGBTs operating at 200°C? An investigation on the potentials and the design constraints von Schlapbach, U., Rahimo, M., von Arx, C., Mukhitdinov, A., Linder, S.

Volltext

QCD corrections to longitudinal spin asymmetries in $W^\pm$-boson production at RHIC von von Arx, C, Gehrmann, T

Volltext bestellen

QCD corrections to longitudinal spin asymmetries in \(W^\pm\)-boson production at RHIC von C von Arx, Gehrmann, T

Volltext